Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600851.SS Gross Margin

The Gross Margin of Shanghai Haixin Group Co Ltd (600851.SS) is 46.37%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

600851.SS Gross Margin - Historical Value
Date Value
2023-12-31 46.37%
2022-12-31 43.73%
2021-12-31 46.23%
2020-12-31 45.27%
2019-12-31 40.80%
2018-12-31 40.11%
2017-12-31 29.94%
2016-12-31 13.80%
2015-12-31 23.36%
2014-12-31 16.21%
600851.SS Gross Margin - Peers Comparison
Ticker Name Value
600624.SS Shanghai Fudan Forward S&T Co Ltd 42.73%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 52.35%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 72.25%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 68.27%
603669.SS Lionco Pharmaceutical Group Co Ltd 44.50%
605116.SS Aurisco Pharmaceutical Co Ltd 55.31%
002550.SZ Changzhou Qianhong Biopharma Co Ltd 42.61%
300006.SZ Chongqing Lummy Pharmaceutical Co Ltd 63.27%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 76.81%
000915.SZ Shandong WIT Dyne Health Co Ltd 83.80%
300723.SZ ApicHope Pharmaceutical Co Ltd 81.04%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 73.17%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 28.29%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 63.30%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 83.54%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 79.78%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 8.72%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 41.83%
300199.SZ Hybio Pharmaceutical Co Ltd 40.71%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 58.25%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 55.87%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 54.82%
300110.SZ Huaren Pharmaceutical Co Ltd 42.53%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 74.19%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 76.91%
603222.SS Chimin Health Management Co Ltd 42.05%
603566.SS Pulike Biological Engineering Inc 60.76%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.02%